Hochschulschrift
Protection from Cytomegalovirus Infection by Glycoprotein-specific Monoclonal Antibodies
- Alternative title
-
Schutz vor Infektion mit dem Cytomegalievirus durch glykoproteinspezifische monoklonale Antikörper
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Erlangen, Universität Erlangen-Nürnberg, Diss., 2012
- Keyword
-
Cytomegalie-Virus ; Antikörper ; Impfung
Infektion
Infektiologie
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Universitätsbibliothek der Universität Erlangen-Nürnberg
- (when)
-
2013
- Creator
-
Karbach, Astrid
- Contributor
-
Winkler, Thomas
- URN
-
urn:nbn:de:bvb:29-opus-48913
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:48 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Karbach, Astrid
- Winkler, Thomas
- Universitätsbibliothek der Universität Erlangen-Nürnberg
Time of origin
- 2013
Other Objects (12)
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
Monoclonal antibodies
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Human cytomegalovirus envelope glycoprotein B as pathogenicity factor for congenital infection
Glycoengineering of Monoclonal Antibodies
Monoclonal antibodies in transplantation
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Use of monoclonal antibodies to study differentiation of Colletotrichum infection structures
Clinical relevance of new monoclonal antibodies
Immunomodulation by the human cytomegalovirus glycoprotein pUL11
Self-interaction and targeted engineering of monoclonal antibodies
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
Monoclonal antibodies
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Human cytomegalovirus envelope glycoprotein B as pathogenicity factor for congenital infection
Glycoengineering of Monoclonal Antibodies
Monoclonal antibodies in transplantation
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Use of monoclonal antibodies to study differentiation of Colletotrichum infection structures
Clinical relevance of new monoclonal antibodies
Immunomodulation by the human cytomegalovirus glycoprotein pUL11
Self-interaction and targeted engineering of monoclonal antibodies
Protection from cytomegalovirus infection by glycoprotein-specific monoclonal antibodies
Monoclonal antibodies
Glycoprotein N of Human Cytomegalovirus Protects the Virus from Neutralizing Antibodies
Neutralizing Antibodies to Antigenic Domain 5 of Glycoprotein B of Human Cytomegalovirus
Human cytomegalovirus envelope glycoprotein B as pathogenicity factor for congenital infection
Glycoengineering of Monoclonal Antibodies
Monoclonal antibodies in transplantation
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Use of monoclonal antibodies to study differentiation of Colletotrichum infection structures
Clinical relevance of new monoclonal antibodies
Immunomodulation by the human cytomegalovirus glycoprotein pUL11